Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record. The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:10:43.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T01:10:06.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a Home link, replacing the study details and navigation. Access to the study record is blocked on this page due to the error.
    Difference
    22%
    Check dated 2026-09-23T01:29:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.6 to v3.7.0, indicating a new version of the study record was published. This appears to be a metadata update rather than a substantive change to trial details.
    Difference
    0.0%
    Check dated 2026-09-16T00:13:00.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a small template/version update. No study content or visible navigation appears to be altered.
    Difference
    0.0%
    Check dated 2026-09-01T19:35:40.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a small template or documentation update on the page. It does not affect the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T16:15:13.000Z thumbnail image

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.